Google AI

Jabali Raises $5M to Build a Generative AI-Powered Game Engine of the Future

Retrieved on: 
Wednesday, March 6, 2024

SAN FRANCISCO and RALEIGH, N.C., March 6, 2024 /PRNewswire/ -- Jabali, an AI company advancing game engines and empowering visionary game designers and developers, announced that it has raised a $5 million seed round led by BITKRAFT Ventures with participation from Sapphire Sport, Sony Innovation Fund, Canonical Ventures, and angels from Amazon, Google AI, Open AI, and Pinterest. The investment will be used to expand the Jabali team, refine proprietary models, and accelerate the product launch.

Key Points: 
  • The company's generative AI-powered game engine will let users create new types of games and interactive experiences without needing extensive game development knowledge.
  • Jabali is creating a purpose-built, closed-loop feedback workflow and technology for video games and interactive experiences, utilizing the advances in multimodal generative AI.
  • Our engine revisits what a game engine can do, enabling more people to make games and new experiences," shared Jabali Founder and CEO, Vatsal Bhardwaj.
  • Jabali is addressing fundamental shifts in game development requiring multi-modal generative AI technology to be built from the core of the game engine.

S32 Names Dr. Andy Conrad as General Partner

Retrieved on: 
Thursday, February 22, 2024

PALO ALTO, Calif., Feb. 22, 2024 /PRNewswire/ -- S32, a leading venture capital firm founded by Bill Maris after building Google Ventures, today proudly announced the appointment of Dr. Andy Conrad, a leader in the application of technology and advanced data science, as General Partner.

Key Points: 
  • PALO ALTO, Calif., Feb. 22, 2024 /PRNewswire/ -- S32, a leading venture capital firm founded by Bill Maris after building Google Ventures, today proudly announced the appointment of Dr. Andy Conrad, a leader in the application of technology and advanced data science, as General Partner.
  • Dr. Conrad previously held numerous senior roles at Google, having most recently founded and served as the CEO and Executive Chairman of Verily Life Sciences (previously "Google Life Sciences").
  • Before joining Google, Dr. Conrad was the Chief Scientific Officer of Laboratory Corporation of America ("LabCorp"), one of the largest clinical laboratory companies in the world.
  • "Andy is precisely who we want on our side working on behalf of our entrepreneurs and investors," said Andy Harrison, CEO and General Partner of S32.

TSPi and Google Public Sector Modernize U.S. Government Commerce and Trade Missions using AI/ML tools

Retrieved on: 
Tuesday, January 9, 2024

TSPi's R3 nxtData accelerator allows government agencies to rapidly deploy modern data and AI/ML technologies that improve efficiency, increase performance, and accelerate success.

Key Points: 
  • TSPi's R3 nxtData accelerator allows government agencies to rapidly deploy modern data and AI/ML technologies that improve efficiency, increase performance, and accelerate success.
  • "Our nxtData accelerator and close work with Google Public Sector further enables TSPi to transform citizens' services by advancing our clients' modernization journey," said Vishal Suri, CEO, TSPi.
  • "We look forward to working with Google Public Sector to help more federal clients modernize their operations and better engage with their constituents through our nxtData accelerator."
  • "Partners like TSPi are critical in helping our joint clients drive more effective results," said Liz Combs, head of Federal Civilian Partner Ecosystem, Google Public Sector.

UiPath Reports Third Quarter Fiscal 2024 Financial Results

Retrieved on: 
Thursday, November 30, 2023

UiPath, Inc. (NYSE: PATH), a leading enterprise automation software company, today announced financial results for its third quarter fiscal 2024 ended October 31, 2023.

Key Points: 
  • UiPath, Inc. (NYSE: PATH), a leading enterprise automation software company, today announced financial results for its third quarter fiscal 2024 ended October 31, 2023.
  • “I am pleased with our strong third quarter results with ARR growing 24 percent year-over-year to $1.378 billion, driven by the team’s execution and the transformational results we deliver,” said Rob Enslin, UiPath Co-Chief Executive Officer.
  • We expect the variability of the above charges to have a significant, and potentially unpredictable, impact on our future GAAP financial results.
  • *IDC MarketScape: Worldwide Intelligent Document Processing 2023-2024 Vendor Assessment (IDC #US49988723, November 2023)
    UiPath will host a conference call today, Thursday, November 30, 2023, at 5:00 p.m. Eastern Time, to discuss the Company's third quarter fiscal 2024 financial results and its guidance for the fourth quarter fiscal 2024.

The New York Center for Rare Diseases at Montefiore to Partner with GeneDx, PacBio and Google Health to Increase Genomic Testing Options for Bronx Families

Retrieved on: 
Wednesday, November 8, 2023

BRONX, N.Y., Nov. 8, 2023 /PRNewswire/ -- The New York Center for Rare Diseases (NYCRD) at Montefiore, recognized as a Center of Excellence by the National Organization for Rare Disorders (NORD), is partnering with GeneDx, PacBio and Google Health to deliver genetic diagnoses for Bronx families living with rare diseases. The goal of the new partnership is to help identify the genetic causes of, and best treatments for rare diseases that have remained undiagnosed, despite using today's most advanced tests.

Key Points: 
  • On average, the search for a rare disease diagnosis takes five to seven years and can be fraught with misdiagnoses.
  • The focus of this research project on the Bronx in New York City adds a level of complexity to rare disease diagnostics.
  • "Our aim is to illuminate rare disease mysteries and bring answers and hope to families navigating the complexities of a rare disease."
  • Together with PacBio and Montefiore, we can help improve equity in genomics resources and help end long diagnostic odysseys for patients."

Complete Genomics demonstrates technical and commercial momentum in the sequencing market through new customers, partnerships and collaborations less than one year after launching in the U.S.

Retrieved on: 
Tuesday, October 31, 2023

At ASHG, Complete Genomics will highlight experts from Stanford Medicine, UMass Chan Medical School and Praxis Genomics to discuss how affordable and accurate genomic sequencing is changing the face of research.

Key Points: 
  • At ASHG, Complete Genomics will highlight experts from Stanford Medicine, UMass Chan Medical School and Praxis Genomics to discuss how affordable and accurate genomic sequencing is changing the face of research.
  • See the full description of speakers Complete Genomics is bringing to ASHG at completegenomics.com/ashg-2023-event-page .
  • Based in San Jose, CA, Complete Genomics celebrated its U.S. commercial launch of its DNBSEQ™ sequencing product line one year ago at ASHG 2022.
  • "Our collaboration with Complete Genomics underscores our commitment to providing researchers with advanced solutions for sequencing applications."

Equinix Reports Third-Quarter 2023 Results

Retrieved on: 
Wednesday, October 25, 2023

Given strong demand signals and the long duration in delivering new capacity, Equinix continues to expand its global footprint.

Key Points: 
  • Given strong demand signals and the long duration in delivering new capacity, Equinix continues to expand its global footprint.
  • Equinix Fabric® saw continued momentum with record port orders, and Equinix Internet Exchange® had another strong quarter with peak traffic reaching nearly 35 terabits per second.
  • Equinix will discuss its quarterly results for the period ended September 30, 2023, along with its future outlook, in its quarterly conference call on Wednesday, October 25, 2023, at 5:30 p.m.
  • Equinix has made available on its website a presentation designed to accompany the discussion of Equinix's results and future outlook, along with certain supplemental financial information and other data.

Eventbrite Appoints Dr. Pilar Manchón to Board of Directors

Retrieved on: 
Thursday, August 3, 2023

Eventbrite (NYSE: EB), a global events marketplace, today announced the appointment of Dr. Pilar Manchón to the company’s Board of Directors, bringing with her an extensive background in artificial intelligence (AI), including expertise in generative, conversational, and responsible AI.

Key Points: 
  • Eventbrite (NYSE: EB), a global events marketplace, today announced the appointment of Dr. Pilar Manchón to the company’s Board of Directors, bringing with her an extensive background in artificial intelligence (AI), including expertise in generative, conversational, and responsible AI.
  • Currently, Dr. Manchón is the Senior Director of Engineering, Research Strategy at Google AI.
  • “Pilar has been a leading voice in the AI industry for over 25 years.
  • “As one of the world’s largest marketplaces for live events, Eventbrite is an industry leader with an outsized impact on culture,” said Dr. Manchón.

Quick Intel and DEXTools Announce Revolutionary Partnership to Enhance Crypto Safety

Retrieved on: 
Thursday, June 1, 2023

DENVER, June 1, 2023 /PRNewswire/ -- Quick Intel (quickintel.io), a leading crypto safety company, announced this week its groundbreaking partnership with DEXTools (dextools.io), a renowned cryptocurrency charting website dedicated to empowering traders in the decentralized exchange ecosystem. By combining their strengths, these industry leaders will reshape how crypto enthusiasts perceive and engage with cryptocurrencies, providing a safer and more transparent environment for all. This collaboration will enable users to:

Key Points: 
  • DENVER, June 1, 2023 /PRNewswire/ -- Quick Intel (quickintel.io), a leading crypto safety company, announced this week its groundbreaking partnership with DEXTools (dextools.io), a renowned cryptocurrency charting website dedicated to empowering traders in the decentralized exchange ecosystem.
  • Quick Intel is a utility token on the Arbitrum blockchain dedicated to providing the crypto community with innovative safety tools and technologies to help investors and traders mitigate risks and combat fraudulent activities.
  • Furthermore, the integration will enhance Quick Intel's platform with DEXTools' invaluable data analysis and visualization tools.
  • Basic safety tools are free, and access to more features is available for purchase on Quick Intel's website.

Grounded Generation from Vectara Defines a New Gold Standard for Generative AI Use for Business Data

Retrieved on: 
Tuesday, May 30, 2023

With this release, Vectara empowers developers to rapidly and easily build conversational AI products with world-class retrieval, summarization, and data privacy directly on top of the data that matters to their business.

Key Points: 
  • With this release, Vectara empowers developers to rapidly and easily build conversational AI products with world-class retrieval, summarization, and data privacy directly on top of the data that matters to their business.
  • These citations support fact-checking and substantially reduce hallucinations, providing business users with the peace of mind that Vectara will only base its generative responses on the factual information – documents and other data – that they’ve provided to Vectara.
  • In addition to countering hallucination, Vectara is also improving search efficacy with its enhanced Hybrid Search.
  • Unlike many API providers, Vectara does not train its models on its customers’ data, such as indexed data or queries.